(310) 826-8600

Guild’s Basic Needs Index

February’s Goldilocks Jobs Numbers

Among many investors and analysts, there’s a growing sense that rising growth, inflation, and interest rates are bringing and end to the long “Goldilocks” phase of the bull market that began nine years ago this month.  That doesn’t mean that stocks have no more gains to deliver — far from

Read More »

Monty Guild Podcast March 9 2018

Our founder and chief investment officer Monty Guild summarizes the global markets and the recent U.S. market correction. He highlights the sectors and industries that will benefit in this environment.

Read More »

Trade Wars and Media Fears

Trade Wars and Media Fears  It was a disappointing February. After a seemingly relentless and exuberant rally during January, the market stumbled in February and ultimately gave back most of its gains year-to-date, although at this writing it is slightly in the green. However, our big-picture analysis continues to suggest

Read More »

The Crypto Capital on the Shores of Lake Zug

In January, 2009, bitcoin’s founder, known only by the pseudonym “Satoshi Nakamoto,” launched the cryptocurrency era by mining the first bitcoin block.  Since then it has been a wild ride for bitcoin users, enthusiasts, speculators, and traders, with digital assets ranking as among the most volatile financial assets in history.  

Read More »

REGISTER NOW: Opportunities In the Late-Cycle Bull

We said in our last conference call that the bull market was not dead.  As 2018 gets underway, the U.S. stock market continues to rally — but what lies ahead in the coming year? Can investors expect further bullish performance from stocks?  Some observers believe the market has already anticipated

Read More »

The new secret weapon against superbugs: dirt.

New Antibiotics Revealed In Humble Soil This week we’re taking a break from commenting extensively on the market’s gyrations, and looking a little more long-term at some new developments in biotechnology. What Really Boosts the Longevity of Human Populations? Some cutting edge biosciences, such as novel cancer therapies, get a

Read More »

We’ve moved!

Here you’ll find the historical archives of Guild’s Global Market Commentary, and our occasional public posts. To read all our content, please visit our Substack page to subscribe.